Yemen Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Yemen Health Report.

Press releases published on July 14, 2026

43 minutes ago

Smile Doctors Outpaces First-Half Growth Plan, Nears 600 Locations Nationwide

Indeterminate GlobeNewswire

an hour ago

PetMeds and Rural King Expand Access to Pet Healthcare Through New Online Pharmacy Platform

Indeterminate GlobeNewswire

an hour ago

Home Instead Named to TIME America’s Best Private Companies 2026 List

Indeterminate GlobeNewswire

an hour ago

FDA Grants Fast Track Designation to SOTIO’s SOT109, a CDH17-targeting ADC for Colorectal Cancer

Indeterminate GlobeNewswire

an hour ago

Humacyte Appoints Key Nephrologists as Advisors to Prepare for Planned Commercialization of the ATEV in Dialysis Access

Indeterminate GlobeNewswire

an hour ago

Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event

Indeterminate GlobeNewswire

an hour ago

Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility

Indeterminate GlobeNewswire

an hour ago

AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding 

Indeterminate GlobeNewswire

an hour ago

Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor

Indeterminate GlobeNewswire

an hour ago

PetVivo Holdings Announces Publication of Peer-Reviewed Clinical Study Evaluating Spryng® in Veterinary Record

Indeterminate GlobeNewswire

an hour ago

Hemab Therapeutics Presents Clinical and Preclinical Data from Sutacimig in Glanzmann Thrombasthenia and Factor VII Deficiency at the ISTH 2026 Congress

Indeterminate GlobeNewswire

an hour ago

Plus Therapeutics Highlights NCCN CNS Cancers Guidelines Update and Reinforces Clinical Role of CNSide® in Leptomeningeal Metastases Monitoring

Indeterminate GlobeNewswire

an hour ago

CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)

Indeterminate GlobeNewswire

an hour ago

InnoCare Announces Publication in STTT (IF=81.2) of Phase 3 Results Showing Orelabrutinib Significantly Prolonged Progression-Free Survival in Treatment-Naïve CLL/SLL

Indeterminate GlobeNewswire

2 hours ago

Axiom Biosciences Reports Positive Phase 1 Results for Investigational Stem Cell Therapy in Newborns with Severe Brain Injury

Indeterminate GlobeNewswire

2 hours ago

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Indeterminate GlobeNewswire

2 hours ago

Verano Hosting Grand Opening Celebration of MÜV Bradfordville on Friday, July 17th, Elevating the Company’s Retail Footprint to 86 Florida Dispensaries and 163 Locations Nationwide

Indeterminate GlobeNewswire

2 hours ago

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

Indeterminate GlobeNewswire

2 hours ago

Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10

Indeterminate GlobeNewswire

2 hours ago

Can-Fite Secures Australian Patent Allowance Supporting Namodenoson Development and Marketing in Liver and Pancreatic Cancer

Indeterminate GlobeNewswire